The anatomic distribution and pathological characteristics of prostate cancer: A mapping analysis

Korean Journal of Urology

Volumn 47, Issue 6, 2006, Pages 578-585

  Kang, Taejin ^a   Song, Cheryn ^a   Song, Gee Hyun ^a   Shin, Gil Hyun ^a   Shin, Dong Ik ^a   Kim, Choung Soo ^a   Ahn, Hanjong ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Maps; Prostate neoplasms; Tumor burden

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ALGORITHM; ANALYSIS OF VARIANCE; ANTIGEN DETECTION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER STAGING; COMPUTER ANALYSIS; COMPUTER PROGRAM; EJACULATORY DUCT; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; KOREA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREOPERATIVE EVALUATION; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE; TUMOR VOLUME;

EID: 33748454419     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.6.578     Document Type: Article

References (24)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA cancer. J Clin 2000;50:7-33
2. 1 Annual report of the Korea central cancer registry (based on registered data from 134 hospitals). Korea central cancer registry, ministry of health and welfare republic of Korea, 2003
3. Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol 1989;142:66-70
4. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12: 897-906
5. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000;89:1800-9
6. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of non-palpable (stage T1c) prostate cancer. JAMA 1994;271:368-74
7. Igel TC, Knight MK, Young PR, Wehle MJ, Petrou SP, Broderick GA, et al. Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk. J Urol 2001;165:1575-9
8. Demura T, Hioka T, Furuno T, Kaneta T, Gotoda H, Muraoka S, et al. Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy. Cancer 2005;103:1826-32
9. Noguchi M, Stamey TA, McNeal JE, Yemoto CE. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol 2000;163:1751-5
10. McNeal JE, Bostwick DG. Anatomy of the prostate: implication for disease. In: Bostwick DG, editor. Pathology of the prostate. 1st ed. New York: Churchill-Livingstone; 1990;1-14
11. Stamey TA, Dietrick DD, Issa MM. Large, organ confined, impalpable transition zone prostate cancer: association with metastatic level of prostate specific antigen. J Urol 1993;149: 510-5
12. Keetch DW, Catalona WJ. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values. J Urol 1995; 154:1795-7
13. McNeal J, Noldus J. Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia. Urology 1996; 48:751-6
14. Chen ME, Troncoso P, Tang K, Babaian RJ, Johnston D. Comparison of prostate biopsy schemes by computer simulation. Urology 1999;53:951-60
15. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1000 consecutive patients. J Urol 2002;167:528-34
16. Villers AA, McNeal JE, Redwine EA, Freiha FS, Stamey TA. Pathogenesis and biological significance of seminal vesicle invasion in prostatic adenocarcinoma. J Urol 1990;143:1183-7
17. Ohori M, Scardino PT, Lapin SL, Seale-Hawkins C, Link J, Wheeler TM. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer. Am J Surg Pathol 1993;17:1252-61
18. Lee F, Torp-Pedersen ST, Siders DB, Littrup PJ, McLeary RD. Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology 1989;170:609-15
19. Ayala AG, Ro JY, Babaian R, Troncoso P, Grignon DJ. The prostatic capsule: Does it exist? Its importance in the staging and treatment of prostatic carcinoma. Am J Surg Pathol 1989; 13:21-7
20. Lee TK, Chung TG, Kim CS. Age-specific reference ranges for prostate specific antigen from a health center in Korea. Korean J Urol 1999;40:583-8
21. Lee SE, Kim DY, Kwak C. Interrelationship among age, prostate specific antigen and prostate volume in Korean men living at the Metropolitan area. Korean J Urol 1999;40:1311-7
22. Cho HS, Kim CS, Ahn H. The pathological characteristics of localized prostate cancer, nanaged with radical prostatectomy. Korean J Urol 2002;43:938-43
23. Furuya Y, Ohta S, Sato N, Kotake T, Masai M. Comparison of T1c versus T2 prostate cancers in Japanese patients undergoing radical prostatectomy. Int Urol Nephrol 2002;33:73-6
24. Song CR, Kim JB, Chung H, Kim CS, Ro JY, Ahn HJ. Nomograms for the prediction of the pathological stage of the clinically localized prostate cancer in Korean men. Korean J Urol 2003;44:753-8